alexa Crystal Structures Of A UbiA Superfamily Prenyltransferase
ISSN: 2155-9570

Journal of Clinical & Experimental Ophthalmology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

4th International Conference on Clinical & Experimental Ophthalmology
July 14-16, 2014 DoubleTree by Hilton Baltimore-BWI Airport, USA

Weikai Li
ScientificTracks Abstracts: J Clin Exp Ophthalmol
DOI: 10.4172/2155-9570.S1.017
UBIAD1 is a eukaryotic member of the UbiA superfamily prenyltranferases that catalyze a key synthetic step of ubiquinones, menaquinones, chlorophylls, hemes, and vitamin E. These lipophilic aromatic compounds are released into membranes to serve as electron and proton carriers for cellular respiration and photosynthesis and as antioxidants to reduce cell damage. Here we report the first crystal structures from the superfamily that capture an archaealUbiA in its apo and substrate-bound states.The structures reveal nine transmembrane helices and an extra-membrane cap domain that surround a large central cavity containing the active site. To facilitate the catalysis inside membranes, UbiA has evolved a unique active site that opens laterally to the lipid bilayer. The UbiA structures provide a framework to understand disease-related mutations inUBIAD1.
Weikai Li received his graduate training of structural biology at Yale in the laboratory of Tom Steitz. As a postdoctoral fellow in Tom Rapoport's Lab at Harvard Medical School, Li learned structural and biochemical techniques to study membrane proteins. Li is currently an assistant professor at Washington University in St. Louis, and his research program focuses on intramembrane enzymes related to hematology. His lab has determined crystal structures of vitamin K epoxide reductase (VKOR), which is a key enzyme that supports blood coagulation and disulfide-bond formation. VKOR is the target of warfarin; the most commonly used oral anticoagulant. More recently, the Li lab has solved the first structure in the UbiA superfamily, which synthesizes lipophilic aromatic compounds (e.g. ubiquinones) that play essential roles in biological membranes.
image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version